Real time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC Read more about Real time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma Read more about Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma
Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy Read more about Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer Read more about A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer
Multiplex Immunofluorescence Assay, MultiOmyx: Detection and deep profiling of immune cells in HBV-infected liver biopsies Read more about Multiplex Immunofluorescence Assay, MultiOmyx: Detection and deep profiling of immune cells in HBV-infected liver biopsies
A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability Read more about A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability
Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle TICA™ Read more about Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle TICA™
Quantifying perivascular immune cells in the stroma of human triple negative breast tumors using deep learning spatial analytics Read more about Quantifying perivascular immune cells in the stroma of human triple negative breast tumors using deep learning spatial analytics
Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study Read more about Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study
Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach Read more about Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach